Current multifunctional albumin-based nanoplatforms for cancer multi-mode therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapy

Background:

• Albumin's biocompatibility and abundance make it ideal for drug delivery in cancer therapy.
• Multifunctional albumin-based nanoplatforms (MAlb-NPs) integrate imaging and therapeutic capabilities for cancer diagnosis and treatment.

Purpose of the Study:

• To review stimuli-responsive albumin nanoplatforms for combinational theranostics.
• To emphasize strategies for low-toxicity cancer therapy and improved treatment outcomes.

Main Methods:

• Focus on stimuli-responsive release mechanisms (reduction-sensitive, pH-responsive, etc.).
• Integration of multiple imaging techniques with therapeutic approaches.
• Development of albumin-based nanoplatforms for synergistic effects.

Main Results:

• Stimuli-responsive release enhances targeted drug delivery and reduces toxicity.
• Combinational theranostics improve treatment efficacy and minimize drug resistance.
• Albumin nanoplatforms offer versatile properties for advanced cancer care.

Conclusions:

• Stimuli-responsive albumin nanoplatforms represent a promising strategy for effective and low-toxicity cancer theranostics.
• Combinational approaches are crucial for overcoming challenges in current cancer treatment.